0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Sleep-Wake Disorder - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-38H8783
Home | Market Reports | Health| Mental Health
Global Sleep Wake Disorder Market Research Report 2022
BUY CHAPTERS

Sleep-Wake Disorder - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-38H8783
Report
November 2024
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sleep-Wake Disorder - Market Size

The global market for Sleep-Wake Disorder was estimated to be worth US$ 17200 million in 2023 and is forecast to a readjusted size of US$ 28080 million by 2030 with a CAGR of 7.2% during the forecast period 2024-2030

Sleep-Wake Disorder - Market

Sleep-Wake Disorder - Market

The sleep-wake disorder is a sign of an impending condition such as bipolar disorder. Sleep disorders range from insomnia disorder to narcolepsy and breathing-related disorder to restless leg syndrome.
The major factors driving the market include the increasing incidences of sleep apnea, an increase in the geriatric population, an increase in the prevalence of obesity and hypertension, and increasing awareness among the patient population in developing countries. Aging is a major factor driving the market growth for sleep apnea devices as the elderly are the most at risk for developing this disorder.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sleep-Wake Disorder, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Sleep-Wake Disorder by region & country, by Type, and by Application.
The Sleep-Wake Disorder market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sleep-Wake Disorder.
Market Segmentation

Scope of Sleep-Wake Disorder - Market Report

Report Metric Details
Report Name Sleep-Wake Disorder - Market
Forecasted market size in 2030 US$ 28080 million
CAGR 7.2%
Forecasted years 2024 - 2030
Segment by Type:
  • Insomnia
  • Hypersomnia
  • Sleep Apnea
  • Circadian Rhythm Disorders
  • Others
Segment by Application
  • Therapies
  • Medications
  • Devices
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Jazz Pharmaceuticals, Koninklijke Philips N.V., Merck KGaA, Neurocrine Biosciences, RespireRx Pharmaceuticals Inc., Medtronic PLC, Teva Pharmaceutical Industries Ltd., Vanda Pharmaceuticals Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Sleep-Wake Disorder manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Sleep-Wake Disorder in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Sleep-Wake Disorder in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Sleep-Wake Disorder - Market size in 2030?

Ans: The Sleep-Wake Disorder - Market size in 2030 will be US$ 28080 million.

Who are the main players in the Sleep-Wake Disorder - Market report?

Ans: The main players in the Sleep-Wake Disorder - Market are Jazz Pharmaceuticals, Koninklijke Philips N.V., Merck KGaA, Neurocrine Biosciences, RespireRx Pharmaceuticals Inc., Medtronic PLC, Teva Pharmaceutical Industries Ltd., Vanda Pharmaceuticals Inc.

What are the Application segmentation covered in the Sleep-Wake Disorder - Market report?

Ans: The Applications covered in the Sleep-Wake Disorder - Market report are Therapies, Medications, Devices

What are the Type segmentation covered in the Sleep-Wake Disorder - Market report?

Ans: The Types covered in the Sleep-Wake Disorder - Market report are Insomnia, Hypersomnia, Sleep Apnea, Circadian Rhythm Disorders, Others

1 Market Overview
1.1 Sleep-Wake Disorder Product Introduction
1.2 Global Sleep-Wake Disorder Market Size Forecast
1.3 Sleep-Wake Disorder Market Trends & Drivers
1.3.1 Sleep-Wake Disorder Industry Trends
1.3.2 Sleep-Wake Disorder Market Drivers & Opportunity
1.3.3 Sleep-Wake Disorder Market Challenges
1.3.4 Sleep-Wake Disorder Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Sleep-Wake Disorder Players Revenue Ranking (2023)
2.2 Global Sleep-Wake Disorder Revenue by Company (2019-2024)
2.3 Key Companies Sleep-Wake Disorder Manufacturing Base Distribution and Headquarters
2.4 Key Companies Sleep-Wake Disorder Product Offered
2.5 Key Companies Time to Begin Mass Production of Sleep-Wake Disorder
2.6 Sleep-Wake Disorder Market Competitive Analysis
2.6.1 Sleep-Wake Disorder Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Sleep-Wake Disorder Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleep-Wake Disorder as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Insomnia
3.1.2 Hypersomnia
3.1.3 Sleep Apnea
3.1.4 Circadian Rhythm Disorders
3.1.5 Others
3.2 Global Sleep-Wake Disorder Sales Value by Type
3.2.1 Global Sleep-Wake Disorder Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Sleep-Wake Disorder Sales Value, by Type (2019-2030)
3.2.3 Global Sleep-Wake Disorder Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Therapies
4.1.2 Medications
4.1.3 Devices
4.2 Global Sleep-Wake Disorder Sales Value by Application
4.2.1 Global Sleep-Wake Disorder Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Sleep-Wake Disorder Sales Value, by Application (2019-2030)
4.2.3 Global Sleep-Wake Disorder Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Sleep-Wake Disorder Sales Value by Region
5.1.1 Global Sleep-Wake Disorder Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Sleep-Wake Disorder Sales Value by Region (2019-2024)
5.1.3 Global Sleep-Wake Disorder Sales Value by Region (2025-2030)
5.1.4 Global Sleep-Wake Disorder Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Sleep-Wake Disorder Sales Value, 2019-2030
5.2.2 North America Sleep-Wake Disorder Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Sleep-Wake Disorder Sales Value, 2019-2030
5.3.2 Europe Sleep-Wake Disorder Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Sleep-Wake Disorder Sales Value, 2019-2030
5.4.2 Asia Pacific Sleep-Wake Disorder Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Sleep-Wake Disorder Sales Value, 2019-2030
5.5.2 South America Sleep-Wake Disorder Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Sleep-Wake Disorder Sales Value, 2019-2030
5.6.2 Middle East & Africa Sleep-Wake Disorder Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Sleep-Wake Disorder Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Sleep-Wake Disorder Sales Value
6.3 United States
6.3.1 United States Sleep-Wake Disorder Sales Value, 2019-2030
6.3.2 United States Sleep-Wake Disorder Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Sleep-Wake Disorder Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Sleep-Wake Disorder Sales Value, 2019-2030
6.4.2 Europe Sleep-Wake Disorder Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Sleep-Wake Disorder Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Sleep-Wake Disorder Sales Value, 2019-2030
6.5.2 China Sleep-Wake Disorder Sales Value by Type (%), 2023 VS 2030
6.5.3 China Sleep-Wake Disorder Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Sleep-Wake Disorder Sales Value, 2019-2030
6.6.2 Japan Sleep-Wake Disorder Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Sleep-Wake Disorder Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Sleep-Wake Disorder Sales Value, 2019-2030
6.7.2 South Korea Sleep-Wake Disorder Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Sleep-Wake Disorder Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Sleep-Wake Disorder Sales Value, 2019-2030
6.8.2 Southeast Asia Sleep-Wake Disorder Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Sleep-Wake Disorder Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Sleep-Wake Disorder Sales Value, 2019-2030
6.9.2 India Sleep-Wake Disorder Sales Value by Type (%), 2023 VS 2030
6.9.3 India Sleep-Wake Disorder Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Jazz Pharmaceuticals
7.1.1 Jazz Pharmaceuticals Profile
7.1.2 Jazz Pharmaceuticals Main Business
7.1.3 Jazz Pharmaceuticals Sleep-Wake Disorder Products, Services and Solutions
7.1.4 Jazz Pharmaceuticals Sleep-Wake Disorder Revenue (US$ Million) & (2019-2024)
7.1.5 Jazz Pharmaceuticals Recent Developments
7.2 Koninklijke Philips N.V.
7.2.1 Koninklijke Philips N.V. Profile
7.2.2 Koninklijke Philips N.V. Main Business
7.2.3 Koninklijke Philips N.V. Sleep-Wake Disorder Products, Services and Solutions
7.2.4 Koninklijke Philips N.V. Sleep-Wake Disorder Revenue (US$ Million) & (2019-2024)
7.2.5 Koninklijke Philips N.V. Recent Developments
7.3 Merck KGaA
7.3.1 Merck KGaA Profile
7.3.2 Merck KGaA Main Business
7.3.3 Merck KGaA Sleep-Wake Disorder Products, Services and Solutions
7.3.4 Merck KGaA Sleep-Wake Disorder Revenue (US$ Million) & (2019-2024)
7.3.5 Neurocrine Biosciences Recent Developments
7.4 Neurocrine Biosciences
7.4.1 Neurocrine Biosciences Profile
7.4.2 Neurocrine Biosciences Main Business
7.4.3 Neurocrine Biosciences Sleep-Wake Disorder Products, Services and Solutions
7.4.4 Neurocrine Biosciences Sleep-Wake Disorder Revenue (US$ Million) & (2019-2024)
7.4.5 Neurocrine Biosciences Recent Developments
7.5 RespireRx Pharmaceuticals Inc.
7.5.1 RespireRx Pharmaceuticals Inc. Profile
7.5.2 RespireRx Pharmaceuticals Inc. Main Business
7.5.3 RespireRx Pharmaceuticals Inc. Sleep-Wake Disorder Products, Services and Solutions
7.5.4 RespireRx Pharmaceuticals Inc. Sleep-Wake Disorder Revenue (US$ Million) & (2019-2024)
7.5.5 RespireRx Pharmaceuticals Inc. Recent Developments
7.6 Medtronic PLC
7.6.1 Medtronic PLC Profile
7.6.2 Medtronic PLC Main Business
7.6.3 Medtronic PLC Sleep-Wake Disorder Products, Services and Solutions
7.6.4 Medtronic PLC Sleep-Wake Disorder Revenue (US$ Million) & (2019-2024)
7.6.5 Medtronic PLC Recent Developments
7.7 Teva Pharmaceutical Industries Ltd.
7.7.1 Teva Pharmaceutical Industries Ltd. Profile
7.7.2 Teva Pharmaceutical Industries Ltd. Main Business
7.7.3 Teva Pharmaceutical Industries Ltd. Sleep-Wake Disorder Products, Services and Solutions
7.7.4 Teva Pharmaceutical Industries Ltd. Sleep-Wake Disorder Revenue (US$ Million) & (2019-2024)
7.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments
7.8 Vanda Pharmaceuticals Inc.
7.8.1 Vanda Pharmaceuticals Inc. Profile
7.8.2 Vanda Pharmaceuticals Inc. Main Business
7.8.3 Vanda Pharmaceuticals Inc. Sleep-Wake Disorder Products, Services and Solutions
7.8.4 Vanda Pharmaceuticals Inc. Sleep-Wake Disorder Revenue (US$ Million) & (2019-2024)
7.8.5 Vanda Pharmaceuticals Inc. Recent Developments
8 Industry Chain Analysis
8.1 Sleep-Wake Disorder Industrial Chain
8.2 Sleep-Wake Disorder Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Sleep-Wake Disorder Sales Model
8.5.2 Sales Channel
8.5.3 Sleep-Wake Disorder Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Sleep-Wake Disorder Market Trends
    Table 2. Sleep-Wake Disorder Market Drivers & Opportunity
    Table 3. Sleep-Wake Disorder Market Challenges
    Table 4. Sleep-Wake Disorder Market Restraints
    Table 5. Global Sleep-Wake Disorder Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Sleep-Wake Disorder Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Sleep-Wake Disorder Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Sleep-Wake Disorder Product Type
    Table 9. Key Companies Time to Begin Mass Production of Sleep-Wake Disorder
    Table 10. Global Sleep-Wake Disorder Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleep-Wake Disorder as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Sleep-Wake Disorder Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Sleep-Wake Disorder Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Sleep-Wake Disorder Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Sleep-Wake Disorder Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Sleep-Wake Disorder Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Sleep-Wake Disorder Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Sleep-Wake Disorder Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Sleep-Wake Disorder Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Sleep-Wake Disorder Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Sleep-Wake Disorder Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Sleep-Wake Disorder Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Sleep-Wake Disorder Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Sleep-Wake Disorder Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Sleep-Wake Disorder Sales Value by Region (2019-2024) & (%)
    Table 27. Global Sleep-Wake Disorder Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Sleep-Wake Disorder Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Sleep-Wake Disorder Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Sleep-Wake Disorder Sales Value, (2025-2030) & (US$ Million)
    Table 31. Jazz Pharmaceuticals Basic Information List
    Table 32. Jazz Pharmaceuticals Description and Business Overview
    Table 33. Jazz Pharmaceuticals Sleep-Wake Disorder Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Sleep-Wake Disorder Business of Jazz Pharmaceuticals (2019-2024)
    Table 35. Jazz Pharmaceuticals Recent Developments
    Table 36. Koninklijke Philips N.V. Basic Information List
    Table 37. Koninklijke Philips N.V. Description and Business Overview
    Table 38. Koninklijke Philips N.V. Sleep-Wake Disorder Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Sleep-Wake Disorder Business of Koninklijke Philips N.V. (2019-2024)
    Table 40. Koninklijke Philips N.V. Recent Developments
    Table 41. Merck KGaA Basic Information List
    Table 42. Merck KGaA Description and Business Overview
    Table 43. Merck KGaA Sleep-Wake Disorder Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Sleep-Wake Disorder Business of Merck KGaA (2019-2024)
    Table 45. Merck KGaA Recent Developments
    Table 46. Neurocrine Biosciences Basic Information List
    Table 47. Neurocrine Biosciences Description and Business Overview
    Table 48. Neurocrine Biosciences Sleep-Wake Disorder Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Sleep-Wake Disorder Business of Neurocrine Biosciences (2019-2024)
    Table 50. Neurocrine Biosciences Recent Developments
    Table 51. RespireRx Pharmaceuticals Inc. Basic Information List
    Table 52. RespireRx Pharmaceuticals Inc. Description and Business Overview
    Table 53. RespireRx Pharmaceuticals Inc. Sleep-Wake Disorder Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Sleep-Wake Disorder Business of RespireRx Pharmaceuticals Inc. (2019-2024)
    Table 55. RespireRx Pharmaceuticals Inc. Recent Developments
    Table 56. Medtronic PLC Basic Information List
    Table 57. Medtronic PLC Description and Business Overview
    Table 58. Medtronic PLC Sleep-Wake Disorder Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Sleep-Wake Disorder Business of Medtronic PLC (2019-2024)
    Table 60. Medtronic PLC Recent Developments
    Table 61. Teva Pharmaceutical Industries Ltd. Basic Information List
    Table 62. Teva Pharmaceutical Industries Ltd. Description and Business Overview
    Table 63. Teva Pharmaceutical Industries Ltd. Sleep-Wake Disorder Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Sleep-Wake Disorder Business of Teva Pharmaceutical Industries Ltd. (2019-2024)
    Table 65. Teva Pharmaceutical Industries Ltd. Recent Developments
    Table 66. Vanda Pharmaceuticals Inc. Basic Information List
    Table 67. Vanda Pharmaceuticals Inc. Description and Business Overview
    Table 68. Vanda Pharmaceuticals Inc. Sleep-Wake Disorder Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Sleep-Wake Disorder Business of Vanda Pharmaceuticals Inc. (2019-2024)
    Table 70. Vanda Pharmaceuticals Inc. Recent Developments
    Table 71. Key Raw Materials Lists
    Table 72. Raw Materials Key Suppliers Lists
    Table 73. Sleep-Wake Disorder Downstream Customers
    Table 74. Sleep-Wake Disorder Distributors List
    Table 75. Research Programs/Design for This Report
    Table 76. Key Data Information from Secondary Sources
    Table 77. Key Data Information from Primary Sources
    Table 78. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Sleep-Wake Disorder Product Picture
    Figure 2. Global Sleep-Wake Disorder Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Sleep-Wake Disorder Sales Value (2019-2030) & (US$ Million)
    Figure 4. Sleep-Wake Disorder Report Years Considered
    Figure 5. Global Sleep-Wake Disorder Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Sleep-Wake Disorder Revenue in 2023
    Figure 7. Sleep-Wake Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Insomnia Picture
    Figure 9. Hypersomnia Picture
    Figure 10. Sleep Apnea Picture
    Figure 11. Circadian Rhythm Disorders Picture
    Figure 12. Others Picture
    Figure 13. Global Sleep-Wake Disorder Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Sleep-Wake Disorder Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Product Picture of Therapies
    Figure 16. Product Picture of Medications
    Figure 17. Product Picture of Devices
    Figure 18. Global Sleep-Wake Disorder Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 19. Global Sleep-Wake Disorder Sales Value Market Share by Application, 2023 & 2030
    Figure 20. North America Sleep-Wake Disorder Sales Value (2019-2030) & (US$ Million)
    Figure 21. North America Sleep-Wake Disorder Sales Value by Country (%), 2023 VS 2030
    Figure 22. Europe Sleep-Wake Disorder Sales Value (2019-2030) & (US$ Million)
    Figure 23. Europe Sleep-Wake Disorder Sales Value by Country (%), 2023 VS 2030
    Figure 24. Asia Pacific Sleep-Wake Disorder Sales Value (2019-2030) & (US$ Million)
    Figure 25. Asia Pacific Sleep-Wake Disorder Sales Value by Country (%), 2023 VS 2030
    Figure 26. South America Sleep-Wake Disorder Sales Value (2019-2030) & (US$ Million)
    Figure 27. South America Sleep-Wake Disorder Sales Value by Country (%), 2023 VS 2030
    Figure 28. Middle East & Africa Sleep-Wake Disorder Sales Value (2019-2030) & (US$ Million)
    Figure 29. Middle East & Africa Sleep-Wake Disorder Sales Value by Country (%), 2023 VS 2030
    Figure 30. Key Countries/Regions Sleep-Wake Disorder Sales Value (%), (2019-2030)
    Figure 31. United States Sleep-Wake Disorder Sales Value, (2019-2030) & (US$ Million)
    Figure 32. United States Sleep-Wake Disorder Sales Value by Type (%), 2023 VS 2030
    Figure 33. United States Sleep-Wake Disorder Sales Value by Application (%), 2023 VS 2030
    Figure 34. Europe Sleep-Wake Disorder Sales Value, (2019-2030) & (US$ Million)
    Figure 35. Europe Sleep-Wake Disorder Sales Value by Type (%), 2023 VS 2030
    Figure 36. Europe Sleep-Wake Disorder Sales Value by Application (%), 2023 VS 2030
    Figure 37. China Sleep-Wake Disorder Sales Value, (2019-2030) & (US$ Million)
    Figure 38. China Sleep-Wake Disorder Sales Value by Type (%), 2023 VS 2030
    Figure 39. China Sleep-Wake Disorder Sales Value by Application (%), 2023 VS 2030
    Figure 40. Japan Sleep-Wake Disorder Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Japan Sleep-Wake Disorder Sales Value by Type (%), 2023 VS 2030
    Figure 42. Japan Sleep-Wake Disorder Sales Value by Application (%), 2023 VS 2030
    Figure 43. South Korea Sleep-Wake Disorder Sales Value, (2019-2030) & (US$ Million)
    Figure 44. South Korea Sleep-Wake Disorder Sales Value by Type (%), 2023 VS 2030
    Figure 45. South Korea Sleep-Wake Disorder Sales Value by Application (%), 2023 VS 2030
    Figure 46. Southeast Asia Sleep-Wake Disorder Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Sleep-Wake Disorder Sales Value by Type (%), 2023 VS 2030
    Figure 48. Southeast Asia Sleep-Wake Disorder Sales Value by Application (%), 2023 VS 2030
    Figure 49. India Sleep-Wake Disorder Sales Value, (2019-2030) & (US$ Million)
    Figure 50. India Sleep-Wake Disorder Sales Value by Type (%), 2023 VS 2030
    Figure 51. India Sleep-Wake Disorder Sales Value by Application (%), 2023 VS 2030
    Figure 52. Sleep-Wake Disorder Industrial Chain
    Figure 53. Sleep-Wake Disorder Manufacturing Cost Structure
    Figure 54. Channels of Distribution (Direct Sales, and Distribution)
    Figure 55. Bottom-up and Top-down Approaches for This Report
    Figure 56. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

RELATED REPORTS

Global Sensory Deprivation Float Tank Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12B13953
Fri May 23 00:00:00 UTC 2025

Add to Cart

Global Anxiety Relief Supplements Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8U14096
Fri May 23 00:00:00 UTC 2025

Add to Cart

Global Treatment Resistant Depression Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-23D13294
Fri May 23 00:00:00 UTC 2025

Add to Cart

Global TMJ Disorders Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37V13329
Fri May 23 00:00:00 UTC 2025

Add to Cart